RICHC
ARKG icon

Renaissance Investment Consultants Holding Company’s ARK Genomic Revolution ETF ARKG Stock Holding History

Renaissance Investment Consultants Holding Company’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$2.02M Buy
27,587
+10,284
+59% +$603K 1.88% 19
2020
Q2 		$935K Buy
+17,303
New +$742K 1.02% 26

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.35B AUM 46.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
CAN
Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return

Renaissance Investment Consultants Holding Company's ARKG Position: Q3 2020 in Review

Renaissance Investment Consultants Holding Company increased its ARK Genomic Revolution ETF (ARKG) stake by 59% in Q3 2020, buying an estimated $603K and bringing the position to 27,587 shares worth $2.02M. The position accounts for 1.88% of the portfolio, ranked #19.

Renaissance Investment Consultants Holding Company first reported a position in ARKG in Q2 2020 and has held it in 2 quarters since. 243 funds tracked by Wall St. Rank hold ARKG as of Q3 2020.

  • Renaissance Investment Consultants Holding Company held 27,587 shares of ARK Genomic Revolution ETF worth $2.02M as of Q3 2020.
  • Renaissance Investment Consultants Holding Company bought 10,284 ARK Genomic Revolution ETF shares in Q3 2020, an estimated $603K.
  • ARK Genomic Revolution ETF made up 1.88% of Renaissance Investment Consultants Holding Company's portfolio in Q3 2020, its #19 holding.
  • Renaissance Investment Consultants Holding Company first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 2 quarters since.
  • 243 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2020.

Based on Renaissance Investment Consultants Holding Company's 13F filing for Q3 2020, filed 6 Nov 2020.